FDA Generic Drug Approval: How the ANDA Process Works
- Garrett Sorenson
- 7 07 2026 Medication Guides
Explore how the FDA regulates generic drug approval through the ANDA process, ensuring bioequivalence and safety under the Hatch-Waxman Act.
Tag: Hatch-Waxman Act
Regulatory Exclusivity: How Non-Patent Protections Guard Drug Markets
- Garrett Sorenson
- 2 06 2026 Medication Guides
Explore how regulatory exclusivity provides non-patent market protections for drugs. Learn about Hatch-Waxman, biologics exclusivity, and the economic impact on pharma innovation.
ANDA Process: Legal Requirements for Generic Drug Approval in the U.S.
- Garrett Sorenson
- 3 02 2026 Medication Guides
The ANDA process lets generic drug makers get FDA approval by proving their product is bioequivalent to the brand version. Learn the legal requirements, fees, patent rules, and common pitfalls.
What Is an ANDA? Abbreviated New Drug Application Explained
- Garrett Sorenson
- 27 12 2025 Medication Guides
An ANDA, or Abbreviated New Drug Application, is the FDA pathway that allows generic drugs to be approved without repeating costly clinical trials. It's why generics cost 80% less but work just as well as brand-name medications.